Transluminal Technologies
Syracuse, US
Biotech
Founders & leadership
RM
Ronald M CaputoExecutive Officer, Director
DL
Denis L HarringtonDirector
ML
Mikio L MiyawakiDirector
SM
Stephen M GreenExecutive Officer, Director
Reported raises · per SEC filings
Form D private placements$1.5MraisedApr 2020 · 27 investors · Biotechnology
Rule 506(b)$1.5MraisedMay 2015 · 32 investors · Biotechnology
Rule 506(c)Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.